A new study published in the journal Chemical and Pharmaceutical Bulletin shows that storage conditions impact the level of the carcinogen NDMA produced in Zantac. N-nitrosodimethylamine, or NDMA, exists in low levels in the environment and is commonly ingested in the diet. When ingested at low levels, NDMA is not considered a cancer risk to humans. However, in June 2019, independent pharmacy Valisure found dangerously high levels of NDMA during routine testing of Zantac. Research conducted by Valisure and others showed that NDMA contamination in ranitidine is caused by the “‘inherent instability’” of the ranitidine molecule.

zantac label 375x210 Storage conditions impact the level of carcinogens in ZantacAs a result, the U.S. Food and Drug Administration (FDA) requested manufacturers to withdraw all prescription and over-the-counter ranitidine drugs from the market in April 2020.

In August 2020, researchers from the National Institute of Health Sciences in Japan published an article studying the impact of high-temperature storage conditions on ranitidine (Zantac). They found that under higher temperatures, the amount of NDMA in two different brands of ranitidine increased significantly from 0.19 to 116 ppm and from 2.89 to 18 ppm respectively. Additionally, the researchers found that other environmental factors, such as oxygen and moisture levels, impacted the level of NDMA formed in ranitidine. Based on their findings, the researchers discussed the importance of controlling and monitoring storage conditions in order to reduce the potential of NDMA-related health risks.

Beasley Allen continues to investigate claims involving a cancer diagnosis after regular Zantac or ranitidine use. Consumers who may have been affected can contact Frank Woodson or Melissa Prickett, lawyers in our Mass Torts Section, for more information.

This story appears in the November 2020 issue of The Jere Beasley Report. For more like this, visit the Report online and subscribe.

Jere L. Beasley, Beasley Allen Founder
Jere Beasley

Jere Beasley, the founding member of Beasley Allen Law Firm, has practiced law as an advocate for victims of wrongdoing since 1962. He was the lead Beasley Allen attorney in the record $11.9 billion award against ExxonMobil Corp. on behalf of the state of Alabama.


We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip